MVIS US Listed Biotech 25 Index

The MVIS US Listed Biotech 25 Index (MVBBH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the biotech industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from biotech related products and services, such as research and development, production, or marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Components

The MVIS US Listed Biotech 25 Index counts currently 25 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-25 of total 25
ComponentCountryWeight
AMGEN INCUS13.43%
GILEAD SCIENCES INCUS8.01%
MODERNA INCUS7.66%
VERTEX PHARMACEUTICALS INCUS6.44%
REGENERON PHARMACEUTICALSUS6.21%
ILLUMINA INCUS6.11%
IQVIA HOLDINGS INCUS5.40%
BIOGEN INCUS5.04%
CHARLES RIVER LABORATORIESUS3.82%
BIO-TECHNE CORPUS3.66%
SEAGEN INCUS3.55%
ICON PLCIE3.37%
EXACT SCIENCES CORPUS2.82%
BIONTECH SEDE2.81%
ALNYLAM PHARMACEUTICALS INCUS2.78%
QIAGEN NVNL2.71%
BEIGENE LTD-ADRKY2.61%
BIOMARIN PHARMACEUTICAL INCUS2.46%
INCYTE CORPUS2.30%
GUARDANT HEALTH INCUS1.87%
NOVAVAX INCUS1.69%
NATERA INCUS1.47%
INTELLIA THERAPEUTICS INCUS1.34%
CRISPR THERAPEUTICS AGCH1.23%
10X GENOMICS INCUS1.19%
Items 1-25 of total 25
Up